Related Experiment Video
Updated: Jul 27, 2026
05:53
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Risk factors for the HIV-associated lipodystrophy syndrome in a cross-sectional single-centre study
A Schwenk1, J P Breuer, G Kremer
1Department of Infectious Diseases, St. George s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK. a.schwenk@sghms.ac.uk
European Journal of Medical Research
|November 15, 2000
Summary
Longer protease inhibitor treatment and older age are key risk factors for HIV-associated lipodystrophy syndrome (HALS). Advanced HIV disease also contributes, but nucleoside analogues showed no significant effect.
Area of Science:
- Infectious Diseases
- Immunology
- Endocrinology
Background:
- HIV-associated lipodystrophy syndrome (HALS) presents a significant clinical challenge.
- Understanding the risk factors for HALS is crucial for patient management and prevention.
Purpose of the Study:
- To investigate the risk factors associated with the development of HIV-associated lipodystrophy syndrome (HALS).
Main Methods:
- A cross-sectional study involving 278 HIV-infected outpatients at a German tertiary care center.
- Quantification of body shape changes using linear analogue scales.
- Logistic regression analysis to identify risk factors including antiretroviral drug duration, CD4 cell counts, viral load, and age.
Main Results:
- HALS was diagnosed in 88 patients.
- Increased risk of HALS correlated significantly with longer protease inhibitor treatment duration (RR 1.61 per year).
- Older age and a history of low CD4 cell counts were identified as cofactors; nucleoside analogues did not show a significant contribution.
Conclusions:
- Protease inhibitor toxicity, advanced HIV disease, and aging are supported as pathogenetic factors for HALS.
- No additional effect of nucleoside analogues was observed.
- High correlation among potential risk factors suggests potential confounding in detecting multiple factors in smaller studies.
